GEVA PHARMA: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
GEVA PHARMA
Largest movements
- Receivables within one year -€27,527
down €27,527 (-31.0%), from €88,859 to €61,332
of which Trade receivables: -€24,412
- Stocks and contracts -€15,988
down €15,988 (-8.7%), from €183,617 to €167,629
- Tangible fixed assets -€13,581
down €13,581 (-16.3%), from €83,529 to €69,948
of which Land and buildings: -€12,429
- Trade debts -€27,865
down €27,865 (-33.5%), from €83,279 to €55,414
- Reserves -€14,404
down €14,404 (-7.7%), from €186,061 to €171,657
of which Distributable reserves: -€10,498
- Tax, wage and social debts -€10,641
down €10,641 (-16.6%), from €63,970 to €53,329
of which Taxes: -€12,665
- Debts after one year -€10,142
down €10,142 (-4.0%), from €251,794 to €241,653
- Gross operating margin -€14,652
down €14,652 (-6.0%), from €244,379 to €229,726
- Other operating charges -€4,459
down €4,459 (-23.6%), from €18,887 to €14,428
- Taxes -€3,926
down €3,926 (-18.3%), from €21,425 to €17,499
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €713,909 | €655,182 | -€58,727 | -8.2% |
| Fixed assets | 21/28 | €88,529 | €74,948 | -€13,581 | -15.3% |
| Tangible fixed assets | 22/27 | €83,529 | €69,948 | -€13,581 | -16.3% |
| Land and buildings | 22 | €81,667 | €69,238 | -€12,429 | -15.2% |
| Plant, machinery and equipment | 23 | €1,334 | €710 | -€624 | -46.8% |
| Furniture and vehicles | 24 | €528 | - | -€528 | |
| Financial fixed assets | 28 | €5,000 | €5,000 | = | 0.0% |
| Current assets | 29/58 | €625,380 | €580,233 | -€45,147 | -7.2% |
| Amounts receivable after more than one year | 29 | €120,000 | €120,000 | = | 0.0% |
| Other amounts receivable | 291 | €120,000 | €120,000 | = | 0.0% |
| Stocks and contracts in progress | 3 | €183,617 | €167,629 | -€15,988 | -8.7% |
| Stocks | 30/36 | €183,617 | €167,629 | -€15,988 | -8.7% |
| Amounts receivable within one year | 40/41 | €88,859 | €61,332 | -€27,527 | -31.0% |
| Trade receivables | 40 | €85,744 | €61,332 | -€24,412 | -28.5% |
| Other amounts receivable | 41 | €3,116 | - | -€3,116 | |
| Cash at bank and in hand | 54/58 | €223,639 | €222,425 | -€1,213 | -0.5% |
| Deferred charges and accrued income | 490/1 | €9,265 | €8,847 | -€418 | -4.5% |
| Total equity and liabilities | 10/49 | €713,909 | €655,182 | -€58,727 | -8.2% |
| Equity | 10/15 | €204,781 | €190,377 | -€14,404 | -7.0% |
| Contributions | 10/11 | €18,720 | €18,720 | = | 0.0% |
| Reserves | 13 | €186,061 | €171,657 | -€14,404 | -7.7% |
| Tax-exempt reserves | 132 | €34,064 | €30,159 | -€3,905 | -11.5% |
| Distributable reserves | 133 | €151,996 | €141,498 | -€10,498 | -6.9% |
| Provisions and deferred taxes | 16 | €6,033 | €4,022 | -€2,011 | -33.3% |
| Deferred taxes | 168 | €6,033 | €4,022 | -€2,011 | -33.3% |
| Amounts payable | 17/49 | €503,095 | €460,783 | -€42,312 | -8.4% |
| Amounts payable after more than one year | 17 | €251,794 | €241,653 | -€10,142 | -4.0% |
| Financial debts | 170/4 | €251,794 | €241,653 | -€10,142 | -4.0% |
| Amounts payable within one year | 42/48 | €247,460 | €215,140 | -€32,321 | -13.1% |
| Current portion of amounts payable after more than one year | 42 | €9,957 | €10,142 | +€185 | +1.9% |
| Trade debts | 44 | €83,279 | €55,414 | -€27,865 | -33.5% |
| Suppliers | 440/4 | €83,279 | €55,414 | -€27,865 | -33.5% |
| Taxes, remuneration and social security | 45 | €63,970 | €53,329 | -€10,641 | -16.6% |
| Taxes | 450/3 | €46,061 | €33,396 | -€12,665 | -27.5% |
| Remuneration and social security | 454/9 | €17,909 | €19,933 | +€2,024 | +11.3% |
| Other amounts payable | 47/48 | €90,255 | €96,255 | +€6,000 | +6.6% |
| Accrued charges and deferred income | 492/3 | €3,840 | €3,990 | +€150 | +3.9% |
| Remuneration, social security and pensions | 62 | €110,397 | €109,757 | -€640 | -0.6% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €14,350 | €13,581 | -€769 | -5.4% |
| Other operating charges | 640/8 | €18,887 | €14,428 | -€4,459 | -23.6% |
| Gross operating margin | 9900 | €244,379 | €229,726 | -€14,652 | -6.0% |
| Operating profit (loss) | 9901 | €100,745 | €91,961 | -€8,784 | -8.7% |
| Financial income | 75/76B | €10,941 | €10,093 | -€848 | -7.8% |
| Recurring financial income | 75 | €10,941 | €10,093 | -€848 | -7.8% |
| Financial charges | 65/66B | €5,427 | €4,971 | -€457 | -8.4% |
| Recurring financial charges | 65 | €5,427 | €4,971 | -€457 | -8.4% |
| Profit (loss) for the period before taxes | 9903 | €106,259 | €97,084 | -€9,176 | -8.6% |
| Transfer from deferred taxes | 780 | €2,011 | €2,011 | = | 0.0% |
| Income taxes | 67/77 | €21,425 | €17,499 | -€3,926 | -18.3% |
| Profit (loss) for the period | 9904 | €86,846 | €81,596 | -€5,249 | -6.0% |
| Transfer from tax-exempt reserves | 789 | €3,905 | €3,905 | = | 0.0% |
| Profit (loss) for the period to be appropriated | 9905 | €90,751 | €85,502 | -€5,249 | -5.8% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 16 October 2026 via checked.be.